It was found that overexpression of eEF2K permits increased tumor-cell survival in many types of cancer, including breast, brain, pancreatic, and lung cancer (Karakas and Ozpolat, 2020; Xiao et al., 2020). This evidence concerns the gene EEF2K and cancer.